| Integrative clinical genomics of metastatic cancer DR Robinson, YM Wu, RJ Lonigro, P Vats, E Cobain, J Everett, X Cao, ... Nature 548 (7667), 297-303, 2017 | 778 | 2017 |
| Twenty-five–year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study R Mody, S Li, DC Dover, S Sallan, W Leisenring, KC Oeffinger, Y Yasui, ... Blood, The Journal of the American Society of Hematology 111 (12), 5515-5523, 2008 | 454 | 2008 |
| Integrative clinical sequencing in the management of refractory or relapsed cancer in youth RJ Mody, YM Wu, RJ Lonigro, X Cao, S Roychowdhury, P Vats, KM Frank, ... Jama 314 (9), 913-925, 2015 | 381 | 2015 |
| XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease RA Marsh, L Madden, BJ Kitchen, R Mody, B McClimon, MB Jordan, ... Blood, The Journal of the American Society of Hematology 116 (7), 1079-1082, 2010 | 282 | 2010 |
| Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial R Mody, A Naranjo, C Van Ryn, LY Alice, WB London, BL Shulkin, ... The lancet oncology 18 (7), 946-957, 2017 | 240 | 2017 |
| Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia S Ramchandren, M Leonard, RJ Mody, JE Donohue, J Moyer, ... Journal of the Peripheral Nervous System 14 (3), 184-189, 2009 | 187 | 2009 |
| Clinical sequencing exploratory research consortium: accelerating evidence-based practice of genomic medicine RC Green, KAB Goddard, GP Jarvik, LM Amendola, PS Appelbaum, ... The American Journal of Human Genetics 98 (6), 1051-1066, 2016 | 167 | 2016 |
| Use of [18F]Fluorodeoxyglucose Positron Emission Tomography in Evaluating Locally Recurrent and Metastatic Adrenocortical Carcinoma GC Mackie, BL Shulkin, RC Ribeiro, FP Worden, PG Gauger, RJ Mody, ... The Journal of Clinical Endocrinology & Metabolism 91 (7), 2665-2671, 2006 | 151 | 2006 |
| Irinotecan, temozolomide, and dinutuximab with GM-CSF in children with refractory or relapsed neuroblastoma: a report from the Children’s Oncology Group R Mody, LY Alice, A Naranjo, FF Zhang, WB London, BL Shulkin, ... Journal of Clinical Oncology 38 (19), 2160, 2020 | 129 | 2020 |
| Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial CE Allen, TW Laetsch, R Mody, MS Irwin, MS Lim, PC Adamson, ... Journal of the National Cancer Institute 109 (5), djw274, 2017 | 93 | 2017 |
| Efficacy and safety of CTL019 in the first US phase II multicenter trial in pediatric relapsed/refractory acute lymphoblastic leukemia: results of an interim analysis SL Maude, MA Pulsipher, MW Boyer, SA Grupp, SM Davies, CL Phillips, ... Blood 128 (22), 2801, 2016 | 90 | 2016 |
| Precision medicine in pediatric oncology: Lessons learned and next steps RJ Mody, JR Prensner, J Everett, DW Parsons, AM Chinnaiyan Pediatric blood & cancer 64 (3), e26288, 2017 | 89 | 2017 |
| Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia K Boztug, PS Rosenberg, M Dorda, S Banka, T Moulton, J Curtin, ... The Journal of pediatrics 160 (4), 679-683. e2, 2012 | 85 | 2012 |
| Refractory iron deficiency anemia as the primary clinical manifestation of celiac disease RJ Mody, PI Brown, DS Wechsler Journal of pediatric hematology/oncology 25 (2), 169-172, 2003 | 79 | 2003 |
| Why pediatric patients with cancer visit the emergency department: United States, 2006–2010 EL Mueller, A Sabbatini, A Gebremariam, R Mody, L Sung, ML Macy Pediatric blood & cancer 62 (3), 490-495, 2015 | 75 | 2015 |
| A rapid flow cytometric screening test for X‐linked lymphoproliferative disease due to XIAP deficiency RA Marsh, J Villanueva, K Zhang, AL Snow, HC Su, L Madden, R Mody, ... Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2009 | 69 | 2009 |
| CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response S Stallard, MG Savelieff, K Wierzbicki, B Mullan, Z Miklja, A Bruzek, ... Acta neuropathologica communications 6, 1-4, 2018 | 67 | 2018 |
| Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma C Koschmann, D Zamler, A MacKay, D Robinson, YM Wu, R Doherty, ... Oncotarget 7 (40), 65696, 2016 | 65 | 2016 |
| FDG PET imaging of childhood sarcomas RJ Mody, C Bui, RJ Hutchinson, GA Yanik, VP Castle, KA Frey, ... Pediatric blood & cancer 54 (2), 222-227, 2010 | 62 | 2010 |
| Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas D Pratt, SK Natarajan, A Banda, C Giannini, P Vats, C Koschmann, ... Acta neuropathologica 135, 299-301, 2018 | 58 | 2018 |
